The Georgetown University Memory Disorders Program is dedicated to providing state-of-the-art clinical services for individuals affected by Alzheimer's disease and related disorders and to conducting research aimed at improving treatment options for Alzheimer's disease.
Here are our research studies that are currently recruiting patients.
|Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss (A4)||ADCS/ Eli Lilly and Company|
Eli Lilly and Company
|ADCS/Toyama Chemical Co.|
Check out our Research section for more information on how to participate in our clinical trials.